Low-intensity ultrasound enhances the anticancer activity of cetuximab in human head and neck cancer cells

Experimental and Therapeutic Medicine

Volumn 5, Issue 1, 2013, Pages 11-16

  Masui, Takashi ^a   Ichiro, Ota ^a   Kanno, Masatoshi ^a   Yane, Katsunari ^b   Hosoi, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b KINDAI UNIVERSITY NARA HOSPITAL   (Japan)

Author keywords

Apoptosis; Cetuximab; Head and neck cancer; Low intensity ultrasound

Indexed keywords

CASPASE 3; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; PROPIDIUM IODIDE; TRYPAN BLUE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASSAY; CANCER CELL; CELL KILLING; CELL LINE; CELL VIABILITY; ENZYME ACTIVATION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; LOW INTENSITY ULTRASOUND; PROTEIN EXPRESSION; REACTION TIME; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; STAINING; ULTRASOUND THERAPY; UPREGULATION; WESTERN BLOTTING;

EID: 84869416111     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.739     Document Type: Article

References (41)

1. Fulda S and Debatin KM: Apoptosis pathways in neuroblastoma therapy. Cancer Lett 197: 131-135, 2003.
2. Mandal D, Mazumder A, Das P, Kundu M and Basu J: Fas-, caspase 8-, and caspase 3-dependent signaling regulates the activity of the aminophospholipid translocase and phosphatidyl-serine externalization in human erythrocytes. J Biol Chem 280: 39460-39467, 2005.
3. Ashush H, Rozenszajn LA, Blass M, et al: Apoptosis induction of human myeloid leukemic cells by ultrasound exposure. Cancer Res 60: 1014-1020, 2000.
4. Lagneaux L, de Meulenaer EC, Delforge A, et al: Ultrasonic low-energy treatment: a novel approach to induce apoptosis in human leukemic cells. Exp Hematol 30: 1293-1301, 2002.
5. Honda H, Zhao QL and Kondo T: Effects of dissolved gases and an echo contrast agent on apoptosis induced by ultrasound and its mechanism via the mitochondria-caspase pathway. Ultrasound Med Biol 28: 673-682, 2002.
6. Feril LB Jr, Kondo T, Zhao QL and Ogawa R: Enhancement of hyperthermia-induced apoptosis by non-thermal effects of ultrasound. Cancer Lett 178: 63-70, 2002.
7. Feril LB Jr, Kondo T, Zhao QL, et al: Enhancement of ultrasound-induced apoptosis and cell lysis by echo-contrast agents. Ultrasound Med Biol 29: 331-337, 2003.
8. Abdollahi A, Domhan S, Jenne JW, et al: Apoptosis signals in lymphoblasts induced by focused ultrasound. Faseb J 18: 1413-1414, 2004.
9. Huber PE, Jenne J W, Rastert R, et al: A new noninvasive approach in breast cancer therapy using magnetic resonance imaging-guided focused ultrasound surgery. Cancer Res 61: 8441-8447, 2001.
10. Blana A, Walter B, Rogenhofer S and Wieland WF: High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology 63: 297-300, 2004.
11. Larkin JO, Casey GD, Tangney M, et al: Effective tumor treatment using optimized ultrasound-mediated delivery of bleomycin. Ultrasound Med Biol 34: 406-413, 2008.
12. Feril LB Jr, Kondo T, Cui ZG, et al: Apoptosis induced by the sonomechanical effects of low intensity pulsed ultrasound in a human leukemia cell line. Cancer Lett 221: 145-152, 2005.
13. Feng Y, Tian ZM, Wan MX and Zheng ZB: Low intensity ultrasound-induced apoptosis in human gastric carcinoma cells. World J Gastroenterol 14: 4873-4879, 2008.
14. Lejbkowicz F and Salzberg S: Distinct sensitivity of normal and malignant cells to ultrasound in vitro. Environ Health Perspect 105 (Suppl 6): 1575-1578, 1997.
15. Yoshida T, Kondo T, Ogawa R, et al: Combination of doxorubicin and low-intensity ultrasound causes a synergistic enhancement in cell killing and an additive enhancement in apoptosis induction in human lymphoma U937 cells. Cancer Chemother Pharmacol 61: 559-567, 2008.
16. Watanabe Y, Aoi A, Horie S, et al: Low-intensity ultrasound and microbubbles enhance the antitumor effect of cisplatin. Cancer Sci 99: 2525-2531, 2008.
17. Danno D, Kanno M, Fujimoto S, Feril LB Jr, Kondo T and Nakamura S: Effects of ultrasound on apoptosis induced by anti-CD20 antibody in CD20-positive B lymphoma cells. Ultrason Sonochem 15: 463-471, 2008.
18. Mendelsohn J: Blockade of receptors for growth factors: an anticancer therapy - the fourth annual Joseph H Burchenal American Association of Cancer Research Clinical Research Award Lecture. Clin Cancer Res 6: 747-753, 2000.
19. Feril LB Jr and Kondo T: Major factors involved in the inhibition of ultrasound-induced free radical production and cell killing by pre-sonication incubation or by high cell density. Ultrason Sonochem 12: 353-357, 2005.
20. Bollag DM and Edelstein SJ: Protein methods. Wiley-Liss, New York, 1991.
21. Hayashi K, Motoyama S, Koyota S, et al: REG I enhances chemo- and radiosensitivity in squamous cell esophageal cancer cells. Cancer Sci 99: 2491-2495, 2008.
22. Feng Y, Tian Z and Wan M: Bioeffects of low-intensity ultrasound in vitro: apoptosis, protein profile alteration, and potential molecular mechanism. J Ultrasound Med 29: 963-974, 2010.
23. Tezel A, Sens A, Tuchscherer J and Mitragotri S: Frequency dependence of sonophoresis. Pharm Res 18: 1694-1700, 2001.
24. Chen WS, Matula TJ and Crum LA: The disappearance of ultrasound contrast bubbles: observations of bubble dissolution and cavitation nucleation. Ultrasound Med Biol 28: 793-803, 2002.
25. Miller DL and Dou C: Membrane damage thresholds for 1- to 10-MHz pulsed ultrasound exposure of phagocytic cells loaded with contrast agent gas bodies in vitro. Ultrasound Med Biol 30: 973-977, 2004.
26. Hallow DM, Mahajan AD, McCutchen TE and Prausnitz MR: Measurement and correlation of acoustic cavitation with cellular bioeffects. Ultrasound Med Biol 32: 1111-1122, 2006.
27. Kodama T, Tomita Y, Koshiyama K and Blomley MJ: Transfection effect of microbubbles on cells in superposed ultrasound waves and behavior of cavitation bubble. Ultrasound Med Biol 32: 905-914, 2006.
28. Larina I V, Evers BM and Esenaliev RO: Optimal drug and gene delivery in cancer cells by ultrasound-induced cavitation. Anticancer Res 25: 149-156, 2005.
29. Honda H, Kondo T, Zhao QL, Feril LB Jr and Kitagawa H: Role of intracellular calcium ions and reactive oxygen species in apoptosis induced by ultrasound. Ultrasound Med Biol 30: 683-692, 2004.
30. Firestein F, Rozenszajn LA, Shemesh-Darvish L, Elimelech R, Radnay J and Rosenschein U: Induction of apoptosis by ultrasound application in human malignant lymphoid cells: role of mitochondria-caspase pathway activation. Ann N Y Acad Sci 1010: 163 -166, 2003.
31. Feril LB Jr, Tsuda Y, Kondo T, et al: Ultrasound-induced killing of monocytic U937 cells enhanced by 2,2'-azobis(2-amidino-propane) dihydrochloride. Cancer Sci 95: 181-185, 2004.
32. Koshiyama K, Kodama T, Yano T and Fujikawa S: Structural change in lipid bilayers and water penetration induced by shock waves: molecular dynamics simulations. Biophys J 91: 2198-2205, 2006.
33. Duvshani-Eshet M, Adam D and Machluf M: The effects of albumin-coated microbubbles in DNA delivery mediated by therapeutic ultrasound. J Control Release 112: 156-166, 2006.
34. Taniyama Y, Tachibana K, Hiraoka K, et al: Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 105: 1233-1239, 2002.
35. Kagiya G, Ogawa R, Tabuchi Y, et al: Expression of heme oxygenase-1 due to intracellular reactive oxygen species induced by ultrasound. Ultrason Sonochem 13: 388-396, 2006.
36. Yuan J: Molecular control of life and death. Curr Opin Cell Biol 7: 211-214, 1995.
37. Majno G and Joris I: Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146: 3-15, 1995.
38. Wyllie AH, Kerr JF and Currie AR: Cell death: the signifcance of apoptosis. Int Rev Cytol 68: 251-306, 1980.
39. Kroemer G, Galluzzi L and Brenner C: Mitochondrial membrane permeabilization in cell death. Physiol Rev 87: 99-163, 2007.
40. Ciardiello F and Tortora G: A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res 7: 2958-2970, 2001.
41. Vermorken JB, Trigo J, Hitt R, et al: Open-label, uncontrolled, multicenter phase II study to evaluate the effcacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. J Clin Oncol 25: 2171-2177, 2007.